Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VIMTALABS | BSE
-2.05
-0.47%
Healthcare
Diagnostics & Research
30/09/2023
08/12/2023
434.50
444.85
444.85
431.20
Vimta Labs Limited provides contract research and testing services in India and internationally. It offers product discovery/development post approval/marketing preclinical/early development/study clinical research and development drug life cycle management support bioanalytical analytical central lab genetically modified organisms testing clinical diagnostics environment testing preclinical research and testing food testing and analytical development and EMI/EMC testing services as well as IND/505 (b)(2) enabling/studies; IVPT IVRT and IVBE studies; and testing services for dioxins and furans trace heavy metals label claims radioactive isotopes vitamins and minerals packaging and shelf life. The company provides solutions to agriculture electricals and electronics medical devices speciality chemicals biologics and biosimilars environment health and safety nutraceuticals water and beverages crop care food packaging clinical diagnostics home and personal care and pharmaceuticals industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad India.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
26.0%1 month
28.1%3 months
40.7%6 months
46.0%22.71
0
3.11
0.07
0.05
10.30
2.92
0
870.12M
9.62B
115.30M
0.48
9.49
-51.60
-8.10
14.96
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
38.95
Range1M
51.45
Range3M
198.45
Rel. volume
0.63
Price X volume
1.34M